The DOI matches its Crossref record.
The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.
Open accessAbstract
Fibroblasts transformed by v-src or by related oncogenes encoding activated tyrosine kinases contain elevated levels of polyphosphoinositides with phosphate at the D-3 position of the inositol ring, as a result of the activation of phosphatidylinositol (PI) 3'-kinase. v-src-transformed cells also contain increased levels of PI 3'-kinase activity immunoprecipitable with anti-phosphotyrosine antibodies; furthermore, PI 3'-kinase can be detected in association with the v-Src tyrosine kinase. To identify regions of v-Src that can interact with PI 3'-kinase, the v-Src SH2 and SH3 domains were expressed in bacteria and incubated with lysates of normal chicken embryo fibroblasts. In vitro, the v-Src SH3 domain, but not the SH2 domain, bound PI 3'-kinase in lysates of uninfected chicken embryo fibroblasts. Substitutions of two highly conserved SH3 residues implicated in ligand binding abolished the ability of the v-Src SH3 domain to associate with PI 3'-kinase. Furthermore, the v-Src SH3 domain bound in vitro to the amino-terminal region of the p85 alpha subunit of PI 3'-kinase. These results suggest that the v-Src SH3 domain may mediate an interaction between the v-Src tyrosine kinase and PI 3'-kinase, by direct binding to p85.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Fruman, D. A., Meyers, R. E., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,355
Regulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,172
Structural basis for the binding of proline-rich peptides to SH3 domains
Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., & Schrelber, S. L. (1994) · Cell · doi:10.1016/0092-8674(94)90367-0 · Cited by 1,001
Protein-protein interactions: methods for detection and analysis.
Phizicky, E. M., & Fields, S. (1995) · Microbiological reviews · doi:10.1128/mmbr.59.1.94-123.1995 · Cited by 966
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Pawson, T., & Schlessingert, J. (1993) · Current Biology · doi:10.1016/0960-9822(93)90350-w · Cited by 688
Self-citationFeng, S., Chen, J. K., Yu, H., Simon, J. A., & Schreiber, S. L. (1994) · Science · doi:10.1126/science.7526465 · Cited by 687
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Structure and function of phosphoinositide 3-kinases
Wymann, M. P., & Pirola, L. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00139-8 · Cited by 660
Kapeller, R., & Cantley, L. C. (1994) · BioEssays · doi:10.1002/bies.950160810 · Cited by 638
Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase
Shima, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6649 · Cited by 636
Skorski, T., Bellacosa, A., Nieborowska‐Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6151 · Cited by 567
“Thus, in accordance with pre- vious findings on the mechanisms of PI-3k activation by activated tyrosine kinases (Pleiman et al., 1994; Liu et al., 1993; Kapeller and Cantley, 1994), our results indicate that PI-3k activation by BCR/ABL is dependent on complex formation between the p85 subunit of…”
BackgroundResultInfluentialActivation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.
Rodriguez-Viciana, P., Warne, P. H., Vanhaesebroeck, B., Waterfield, M. D., & Downward, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00602.x · Cited by 566
Differential regulation of cell motility and invasion by FAK
Hsia, D. A., Mitra, S. K., Hauck, C. R., Streblow, D. N., Nelson, J. A., Ilic, D., Huang, S., Li, E., Nemerow, G. R., Leng, J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212114 · Cited by 535
Signaling through focal adhesion kinase
Hanks, S. K., & Polte, T. R. (1997) · BioEssays · doi:10.1002/bies.950190208 · Cited by 469
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
Castoria, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6050 · Cited by 468
Schlessinger, J. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90087-6 · Cited by 453
Activation of Phosphatidylinositol-3′ Kinase by Src-Family Kinase SH3 Binding to the p85 Subunit
Pleiman, C. M., Hertz, W. M., & Cambier, J. C. (1994) · Science · doi:10.1126/science.8128248 · Cited by 436
An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis
Taylor, S. J., & Shalloway, D. (1994) · Nature · doi:10.1038/368867a0 · Cited by 411
Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K., & Lehman, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14733 · Cited by 342
Regulation of the Src Family Kinases by Csk
Okada, M. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.5141 · Cited by 309
“In addition, the c-Src SH3 domain binds to various signaling proteins that contain proline-rich motifs [27], such as Shc, PI3K, Cas, Tks5, and Arhgef5 [28-30].”
BackgroundAbl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren, R., Ye, Z. S., & Baltimore, D. (1994) · Genes & Development · doi:10.1101/gad.8.7.783 · Cited by 311
Gao, N., Flynn, D. C., Zhang, Z., Zhong, X.-S., Walker, V., Liu, K. J., Shi, X., & Jiang, B.-H. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00422.2003 · Cited by 307
TNF Signaling in Vascular Endothelial Cells
Madge, L. A., & Pober, J. S. (2001) · Experimental and Molecular Pathology · doi:10.1006/exmp.2001.2368 · Cited by 305
Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase.
Sumimoto, H., Kage, Y., Nunoi, H., Sasaki, H., Nose, T., Fukumaki, Y., Ohno, M., Minakami, S., & Takeshige, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5345 · Cited by 296
Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer
Gao, N., Zhang, Z., Jiang, B.-H., & Shi, X. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.132 · Cited by 275
Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries.
Rickles, R. J., Botfield, M. C., Weng, Z., Taylor, J. A., Green, O. M., Brugge, J. S., & Zoller, M. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06897.x · Cited by 256
Michels, G., & Hoppe, U. C. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.004 · Cited by 198
Paradoxical activation of c-Src as a drug-resistant mechanism
Higuchi, M., Ishiyama, K., Maruoka, M., Kanamori, R., Takaori-Kondo, A., & Watanabe, N. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108876 · Cited by 31
Metadata
- Authors
- Liu, X., Marengere, L. E., Koch, C. A., & Pawson, T.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-09
- Volume
- 13
- Issue
- 9
- Pages
- 5225-5232
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2138193571
- Cited by
- 178
- References
- 0
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.